ALVIN WILLIAMS: Open Payments
NPI 1083138226 · BOGALUSA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 11 payments from 5 companies in 2025. Trend: 2023 $88 · 2024 $207 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $102 |
| Amgen Inc. | 2 | $35 |
| Dexcom, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
Products named: CAPLYTA, OTEZLA, Dexcom G6 Transmitter, UBRELVY, REXULTI.
Industry payments across LA — which companies pay providers there.
